Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Robbins Geller is investigating whether Kyndryl and certain of its top executives made materially false and/or misleading statements to investors.
-
The Varonis lawsuit alleges that defendants created the false impression that they possessed reliable information regarding projected revenue, growth.
-
Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.
-
The case alleges Richtech Robotics claimed that it had a collaborative and commercial relationship with Microsoft when it did not.
-
$FRMI FRMI Fermi Fermi Inc. Fermi Class Action Lawsuit BW: $FRMI FRMI Fermi FermiInc. FermiClassActionLawsuit The case alleges Fermi Inc. misled investors
-
Oracle allegedly failed to disclose that its AI strategy would result in massive increases in CapEx without equivalent near-term revenue growth.
-
The lawsuit alleges that Masonite had an obligation to disclose it had received formal acquisition offers or abstain from purchasing Masonite stock.
-
Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates.
-
Oracle allegedly failed to disclose that its AI strategy would result in massive increases in CapEx without equivalent near-term revenue growth.
-
The law firm of Robbins Geller is investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT).